Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2007-7-16
pubmed:abstractText
Studies in continuously cultured cells have established that familial Alzheimer's disease (FAD) mutant presenilin 1 (PS1) delays exit of the amyloid precursor protein (APP) from the trans-Golgi network (TGN). Here we report the first description of PS1-regulated APP trafficking in cerebral neurons in culture and in vivo. Using neurons from transgenic mice or a cell-free APP transport vesicle biogenesis system derived from the TGN of those neurons, we demonstrated that knocking-in an FAD-associated mutant PS1 transgene was associated with delayed kinetics of APP arrival at the cell surface. Apparently, this delay was at least partially attributable to impaired exit of APP from the TGN, which was documented in the cell-free APP transport vesicle biogenesis assay. To extend the study to APP and carboxyl terminal fragment (CTF) trafficking to cerebral neurons in vivo, we performed subcellular fractionation of brains from APP transgenic mice, some of which carried a second transgene encoding an FAD-associated mutant form of PS1. The presence of the FAD mutant PS1 was associated with a slight shift in the subcellular localization of both holoAPP and APP CTFs toward iodixanol density gradient fractions that were enriched in a marker for the TGN. In a parallel set of experiments, we used an APP : furin chimeric protein strategy to test the effect of artificially forcing TGN concentration of an APP : furin chimera that could be a substrate for beta- and gamma-cleavage. This chimeric substrate generated excess Abeta42 when compared with wildtype APP. These data indicate that the presence of an FAD-associated mutant human PS1 transgene is associated with redistribution of the APP and APP CTFs in brain neurons toward TGN-enriched fractions. The chimera experiment suggests that TGN-enrichment of a beta-/gamma-secretase substrate may play an integral role in the action of mutant PS1 to elevate brain levels of Abeta42.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0022-3042
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
619-26
pubmed:dateRevised
2011-9-22
pubmed:meshHeading
pubmed-meshheading:17630980-Alzheimer Disease, pubmed-meshheading:17630980-Amyloid beta-Peptides, pubmed-meshheading:17630980-Amyloid beta-Protein Precursor, pubmed-meshheading:17630980-Animals, pubmed-meshheading:17630980-Animals, Newborn, pubmed-meshheading:17630980-Cells, Cultured, pubmed-meshheading:17630980-Cerebral Cortex, pubmed-meshheading:17630980-Flavin-Adenine Dinucleotide, pubmed-meshheading:17630980-Humans, pubmed-meshheading:17630980-Mice, pubmed-meshheading:17630980-Mice, Transgenic, pubmed-meshheading:17630980-Mutant Chimeric Proteins, pubmed-meshheading:17630980-Mutation, pubmed-meshheading:17630980-Neurons, pubmed-meshheading:17630980-Peptide Fragments, pubmed-meshheading:17630980-Presenilin-1, pubmed-meshheading:17630980-Protein Structure, Tertiary, pubmed-meshheading:17630980-Protein Transport, pubmed-meshheading:17630980-Transgenes, pubmed-meshheading:17630980-Up-Regulation, pubmed-meshheading:17630980-trans-Golgi Network
pubmed:year
2007
pubmed:articleTitle
Alzheimer's presenilin 1 modulates sorting of APP and its carboxyl-terminal fragments in cerebral neurons in vivo.
pubmed:affiliation
Farber Institute for Neurosciences and the Department of Neurology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. samgandy@earthlink.net
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural